{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:22:52Z","timestamp":1783113772283,"version":"3.54.6"},"reference-count":162,"publisher":"Bentham Science Publishers Ltd.","issue":"7","funder":[{"DOI":"10.13039\/501100001407","name":"DBT Builder project","doi-asserted-by":"publisher","award":["BT\/INF\/22\/SP45078\/2022"],"award-info":[{"award-number":["BT\/INF\/22\/SP45078\/2022"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Acne vulgaris is a prevalent dermatological condition resulting from inflammation,\nfollicular hyperkeratinization, and bacterial growth. Standard treatments, whether topical or oral, frequently\nencounter challenges such as limited skin penetration, drug instability, and undesirable side effects. The report\nfound that lipid-based nanocarriers have emerged as a promising alternative, demonstrating the potential for\nenhanced therapeutic effectiveness, better skin bioavailability, controlled drug release, and targeted delivery\nspecifically to sebaceous glands, which help minimize systemic side effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>This review article aims to explore the therapeutic potential of various lipid nanocarriers, including Solid\nLipid Nanoparticles (SLNs), Nanostructured Lipid Carriers (NLCs), liposomes, microemulsions, niosomes,\nand ethosomes particularly by examining the mechanisms through which they penetrate the stratum corneum\nand deeper skin layers to enhance drug delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology:<\/jats:title>\n                    <jats:p>This review comprehensively surveys lipid-based nanocarriers for acne vulgaris treatment,\ndrawing from a systematic literature search across Google Scholar, Science Direct, Scopus, Web of Science,\nand PubMed for publications between 2015 and 2025. The search strategy employed keywords such as \"lipid\nnanocarrier,\" \"acne vulgaris,\" \"animal models,\" or \"preclinical studies,\" and \"clinical trials\" to capture the research\nlandscape.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The review compiles evidence from multiple preclinical experiments and clinical trials regarding the\neffectiveness of lipid nanocarriers in managing acne. It explores the different pathways these lipid nanocarriers\nuse to permeate the skin and reach target sites. Additionally, it also covers different patents filed by various\nresearchers focusing on the application of lipid nanocarriers for acne management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Lipid nanocarriers represent a significant advancement in dermatological drug delivery, particularly\nfor acne management. By leveraging various skin penetration mechanisms to improve drug targeting to\nthe pilosebaceous unit, they offer potential for more effective treatment compared to conventional methods.\nWhile promising, ongoing research and development are necessary to overcome current limitations and fully\nharness the potential of lipid nanocarriers in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113816128404408250707111455","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T06:28:36Z","timestamp":1753079316000},"page":"534-555","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lipid-Based Nanocarriers as a Promising Delivery System in the Management of Acne"],"prefix":"10.2174","volume":"32","author":[{"given":"Soumya","family":"Ranjan Masanta","sequence":"first","affiliation":[{"name":"School of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Nilam","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhisek","family":"Pal","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswakanth","family":"Kar","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Dash","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Pradhan","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitu","family":"Halder","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Das","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet","family":"Kumar Rai","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saroj","family":"Kumar Rout","sequence":"additional","affiliation":[{"name":"LNK InternationalInc, Hauppauge, New York, 11788, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutam","family":"Ghosh","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutam","family":"Rath","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"101578","DOI":"10.1016\/j.bbrep.2023.101578","volume":"36","author":"Vasam M.","year":"2023","unstructured":"Vasam M.; Korutla S.; Bohara R.A.; Acne vulgaris: A review of the pathophysiology, treatment, and recent nanotechnology based advances. Biochem Biophys Rep  2023,36,101578","journal-title":"Biochem Biophys Rep"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1156522","DOI":"10.3389\/fpubh.2023.1156522","volume":"11","author":"Liu L.","year":"2023","unstructured":"Liu L.; Xue Y.; Chen Y.; Acne and risk of mental disorders: A two-sample Mendelian randomization study based on large genome-wide association data. Front Public Health  2023,11,1156522","journal-title":"Front Public Health"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.3390\/cells12222600","volume":"12","author":"Melnik B.C.","year":"2023","unstructured":"Melnik B.C.; Acne transcriptomics: Fundamentals of acne pathogenesis and isotretinoin treatment. Cells  2023,12(22),2600","journal-title":"Cells"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.3390\/molecules29081793","volume":"29","author":"Li L.","year":"2024","unstructured":"Li L.; Zhang J.; Cheng W.; Di F.; Wang C.; An Q.; Saponins of Paris polyphylla for the improvement of acne: Anti-inflammatory, antibacterial, antioxidant and immunomodulatory effects. Molecules  2024,29(8),1793","journal-title":"Molecules"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1274270","DOI":"10.3389\/fimmu.2023.1274270","volume":"14","author":"Dainichi T.","year":"2023","unstructured":"Dainichi T.; Iwata M.; Inflammatory loops in the epithelial\u2013immune microenvironment of the skin and skin appendages in chronic inflammatory diseases. Front Immunol  2023,14,1274270","journal-title":"Front Immunol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-3-030-92616-8_6","author":"Elsaie M.L.","year":"2022","unstructured":"Elsaie M.L.; Aly D.G.; The immunogenetics of acne. In: The Immunogenetics of Dermatologic Diseases  2022,137-154","journal-title":"In: The Immunogenetics of Dermatologic Diseases"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.3390\/biomedicines10102523","volume":"10","author":"Condr\u00f2 G.","year":"2022","unstructured":"Condr\u00f2 G.; Guerini M.; Castello M.; Perugini P.; Acne vulgaris, atopic dermatitis and rosacea: The role of the skin microbiota\u2014a review. Biomedicines  2022,10(10),2523","journal-title":"Biomedicines"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2147\/CCID.S359055","volume":"15","author":"Boonchaya P.","year":"2022","unstructured":"Boonchaya P.; Rojhirunsakool S.; Kamanamool N.; Minimum contact time of 1.25%, 2.5%, 5%, and 10% benzoyl peroxide for a bactericidal effect against Cutibacterium acnes. Clin Cosmet Investig Dermatol  2022,15,403-409","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref=9","author":"Agountaf I.","year":"2023","unstructured":"Agountaf I.; Optimizing the use of topical retinoids in Moroccan patients with acne. PhD Thesis, National University of Pharmacy of Ministry of Healthcare of Ukraine, Kharkiv,  2023","journal-title":"PhD Thesis, National University of Pharmacy of Ministry of Healthcare of Ukraine, Kharkiv,"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.2147\/CCID.S453243","volume":"17","author":"Almeman A.","year":"2024","unstructured":"Almeman A.; Evaluating the efficacy and safety of alpha-hydroxy acids in dermatological practice: A comprehensive clinical and legal review. Clin Cosmet Investig Dermatol  2024,17,1661-1685","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"13824","DOI":"10.1111\/dth.13824","volume":"33","author":"Bonamonte D.","year":"2020","unstructured":"Bonamonte D.; De Marco A.; Giuffrida R.; Topical antibiotics in the dermatological clinical practice: Indications, efficacy, and adverse effects. Dermatol Ther  2020,33(6),13824","journal-title":"Dermatol Ther"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"14978","DOI":"10.1111\/dth.14978","volume":"34","author":"Odorici G.","year":"2021","unstructured":"Odorici G.; Monfrecola G.; Bettoli V.; Tetracyclines and photosensitive skin reactions: A narrative review. Dermatol Ther  2021,34(4),14978","journal-title":"Dermatol Ther"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.22159\/ijap.2021v13i2.40045","volume":"13","author":"Sitohang I.B.S.","year":"2021","unstructured":"Sitohang I.B.S.; Isotretinoin for treating acne vulgaris. Int J Appl Pharm  2021,13(2),20-25","journal-title":"Int J Appl Pharm"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"14680","DOI":"10.1111\/dth.14680","volume":"34","author":"Dhurat R.","year":"2021","unstructured":"Dhurat R.; Shukla D.; Lim R.K.; Wambier C.G.; Goren A.; Spironolactone in adolescent acne vulgaris. Dermatol Ther  2021,34(1),14680","journal-title":"Dermatol Ther"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/17512433.2021.1917376","volume":"14","author":"Bagatin E.","year":"2021","unstructured":"Bagatin E.; Rocha M.A.D.; Freitas T.H.P.; Costa C.S.; Treatment challenges in adult female acne and future directions. Expert Rev Clin Pharmacol  2021,14(6),687-701","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/der2.49","volume":"2","author":"Graber E.M.","year":"2021","unstructured":"Graber E.M.; Treating acne with the tetracycline class of antibiotics: A review. Dermatol Rev  2021,2(6),321-330","journal-title":"Dermatol Rev"},{"key":"ref=17","first-page":"26","volume":"16","author":"Stein Gold L.","year":"2023","unstructured":"Stein Gold L.; Kwong P.; Draelos Z.; Impact of topical vehicles and cutaneous delivery technologies on patient adherence and treatment outcomes in acne and rosacea. J Clin Aesthet Dermatol  2023,16(5),26-34","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3390\/ph16040617","volume":"16","author":"Oliveira R.","year":"2023","unstructured":"Oliveira R.; Almeida I.F.; Patient-centric design of topical dermatological medicines. Pharmaceuticals  2023,16(4),617","journal-title":"Pharmaceuticals"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12943-023-01865-0","volume":"22","author":"Chehelgerdi M.","year":"2023","unstructured":"Chehelgerdi M.; Chehelgerdi M.; Allela O.Q.B.; Progressing nanotechnology to improve targeted cancer treatment: Overcoming hurdles in its clinical implementation. Mol Cancer  2023,22(1),169","journal-title":"Mol Cancer"},{"key":"ref=20","doi-asserted-by":"publisher","DOI":"10.2174\/0118746098369369250119112935","volume":"18","author":"Pradhan P.","year":"2025","unstructured":"Pradhan P.; Jana K.; Ghosh S.; Recent advances in bioactive flavonoids-based nanotherapeutics as promising neuroprotectants in epilepsy. Curr Aging Sci  2025,18","journal-title":"Curr Aging Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3390\/pharmaceutics14030533","volume":"14","author":"Jacob S.","year":"2022","unstructured":"Jacob S.; Nair A.B.; Shah J.; Lipid nanoparticles as a promising drug delivery carrier for topical ocular therapy\u2014an overview on recent advances. Pharmaceutics  2022,14(3),533","journal-title":"Pharmaceutics"},{"key":"ref=22","first-page":"649","author":"Dash P.","year":"2025","unstructured":"Dash P.; Halder J.; Rajwar T.K.; Pharmacokinetics of nanoparticles for infectious diseases. In: Applications of Nanotherapeutics and Nanotheranostics in Managing Infectious Diseases  2025,649-663","journal-title":"In: Applications of Nanotherapeutics and Nanotheranostics in Managing Infectious Diseases"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"202405251","DOI":"10.1002\/slct.202405251","volume":"10","author":"Mahanty R.","year":"2025","unstructured":"Mahanty R.; Dubey D.; Pradhan D.; In silico and therapeutic efficacy of glycyrrhizin\u2010based silver nanoparticles against bacteria related to periodontitis. ChemistrySelect  2025,10(1),202405251","journal-title":"ChemistrySelect"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"102437","DOI":"10.1016\/j.cis.2021.102437","volume":"293","author":"Salvioni L.","year":"2021","unstructured":"Salvioni L.; Morelli L.; Ochoa E.; The emerging role of nanotechnology in skincare. Adv Colloid Interface Sci  2021,293,102437","journal-title":"Adv Colloid Interface Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"104990","DOI":"10.1016\/j.tiv.2020.104990","volume":"69","author":"Ellison C.A.","year":"2020","unstructured":"Ellison C.A.; Tankersley K.O.; Obringer C.M.; Partition coefficient and diffusion coefficient determinations of 50 compounds in human intact skin, isolated skin layers and isolated stratum corneum lipids. Toxicol In Vitro  2020,69,104990","journal-title":"Toxicol In Vitro"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"459","DOI":"10.2174\/0122117385269151231031161411","volume":"12","author":"Alam M.","year":"2024","unstructured":"Alam M.; Mishra A.; Yadav K.S.; Development and evaluation of dutasteride nanoemulgel for the topical delivery against Androgenic alopecia. Pharm Nanotechnol  2024,12(5),459-470","journal-title":"Pharm Nanotechnol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1007\/s00289-021-03729-3","volume":"79","author":"Ojha B.","year":"2022","unstructured":"Ojha B.; Jain V.K.; Gupta S.; Talegaonkar S.; Jain K.; Nanoemulgel: A promising novel formulation for treatment of skin ailments. Polym Bull  2022,79(7),4441-4465","journal-title":"Polym Bull"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jconrel.2021.08.016","volume":"338","author":"Keck C.M.","year":"2021","unstructured":"Keck C.M.; Specht D.; Br\u00fc\u00dfler J.; Influence of lipid matrix composition on biopharmaceutical properties of lipid nanoparticles. J Control Release  2021,338,149-163","journal-title":"J Control Release"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.3390\/pharmaceutics16111384","volume":"16","author":"Kang Y.","year":"2024","unstructured":"Kang Y.; Zhang S.; Wang G.; Nanocarrier-based transdermal drug delivery systems for dermatological therapy. Pharmaceutics  2024,16(11),1384","journal-title":"Pharmaceutics"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s41702-020-00062-9","volume":"4","author":"Ahmad A.","year":"2020","unstructured":"Ahmad A.; Ahsan H.; Lipid-based formulations in cosmeceuticals and biopharmaceuticals. Biomed Dermatol  2020,4(1),12","journal-title":"Biomed Dermatol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/colloids5010018","volume":"5","author":"Zoabi A.","year":"2021","unstructured":"Zoabi A.; Touitou E.; Margulis K.; Recent advances in nanomaterials for dermal and transdermal applications. Colloids and Interfaces  2021,5(1),18","journal-title":"Colloids and Interfaces"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2000264","DOI":"10.1002\/ejlt.202000264","volume":"123","author":"Patel D.","year":"2021","unstructured":"Patel D.; Patel B.; Thakkar H.; Lipid based nanocarriers: Promising drug delivery system for topical application. Eur J Lipid Sci Technol  2021,123(5),2000264","journal-title":"Eur J Lipid Sci Technol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s13346-021-00908-7","volume":"11","author":"Plaza-Oliver M.","year":"2021","unstructured":"Plaza-Oliver M.; Santander-Ortega M.J.; Lozano M.V.; Current approaches in lipid-based nanocarriers for oral drug delivery. Drug Deliv Transl Res  2021,11(2),471-497","journal-title":"Drug Deliv Transl Res"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1208\/s12249-024-02884-w","volume":"25","author":"Sharma P.","year":"2024","unstructured":"Sharma P.; Kaul S.; Jain N.; Pandey M.; Nagaich U.; Enhanced skin penetration and efficacy: First and second generation lipoidal nanocarriers in skin cancer therapy. AAPS PharmSciTech  2024,25(6),170","journal-title":"AAPS PharmSciTech"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s11095-020-02866-0","volume":"37","author":"Rodrigues L.B.O.","year":"2020","unstructured":"Rodrigues L.B.O.; Lima F.A.; Alves C.P.B.; Ion pair strategy in solid lipid nanoparticles: A targeted approach to improve epidermal targeting with controlled adapalene release, resulting reduced skin irritation. Pharm Res  2020,37(8),148","journal-title":"Pharm Res"},{"key":"ref=36","first-page":"161","volume":"14","author":"Saeedi M.","year":"2024","unstructured":"Saeedi M.; Morteza-Semnani K.; Akbari J.; Green formulation of spironolactone loaded chitosan-coated nano lipid carrier for treatment of acne vulgaris: A randomized double-blind clinical trial. Adv Pharm Bull  2024,14(1),161-175","journal-title":"Adv Pharm Bull"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"111468","DOI":"10.1016\/j.molliq.2019.111468","volume":"293","author":"Pinto F.","year":"2019","unstructured":"Pinto F.; de Barros D.P.C.; Reis C.; Fonseca L.P.; Optimization of nanostructured lipid carriers loaded with retinoids by central composite design. J Mol Liq  2019,293,111468","journal-title":"J Mol Liq"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/ced.14032","volume":"45","author":"Weinstein A.","year":"2020","unstructured":"Weinstein A.; Koren A.; Sprecher E.; Zur E.; Mehrabi J.N.; Artzi O.; The combined effect of tranilast 8% liposomal gel on the final cosmesis of acne scarring in patients concomitantly treated by isotretinoin: Prospective, double\u2010blind, split\u2010face study. Clin Exp Dermatol  2020,45(1),41-47","journal-title":"Clin Exp Dermatol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"103277","DOI":"10.1016\/j.jddst.2022.103277","volume":"71","author":"Alam A.","year":"2022","unstructured":"Alam A.; Mustafa G.; Agrawal G.P.; A microemulsion-based gel of isotretinoin and erythromycin estolate for the management of acne. J Drug Deliv Sci Technol  2022,71,103277","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"20023","DOI":"10.1038\/s41598-023-47302-6","volume":"13","author":"Ghasemiyeh P.","year":"2023","unstructured":"Ghasemiyeh P.; Moradishooli F.; Daneshamouz S.; Heidari R.; Niroumand U.; Mohammadi-Samani S.; Optimization, characterization, and follicular targeting assessment of tretinoin and bicalutamide loaded niosomes. Sci Rep  2023,13(1),20023","journal-title":"Sci Rep"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1080\/17425247.2019.1645119","volume":"16","author":"Chen Y.","year":"2019","unstructured":"Chen Y.; Feng X.; Meng S.; Site-specific drug delivery in the skin for the localized treatment of skin diseases. Expert Opin Drug Deliv  2019,16(8),847-867","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"21712","DOI":"10.1021\/acsomega.0c02618","volume":"5","author":"Badawi N.","year":"2020","unstructured":"Badawi N.; El-Say K.; Attia D.; El-Nabarawi M.; Elmazar M.; Teaima M.; Development of pomegranate extract-loaded solid lipid nanoparticles: Quality by design approach to screen the variables affecting the quality attributes and characterization. ACS Omega  2020,5(34),21712-21721","journal-title":"ACS Omega"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3390\/pharmaceutics16101270","volume":"16","author":"Safta D.A.","year":"2024","unstructured":"Safta D.A.; Bogdan C.; Moldovan M.L.; SLNs and NLCs for skin applications: Enhancing the bioavailability of natural bioactives. Pharmaceutics  2024,16(10),1270","journal-title":"Pharmaceutics"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2174\/1389201022666210714145356","volume":"23","author":"Varma S.","year":"2022","unstructured":"Varma S.; Dey S.; Palanisamy D.; Cellular uptake pathways of nanoparticles: Process of endocytosis and factors affecting their fate. Curr Pharm Biotechnol  2022,23(5),679-706","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.3390\/molecules27113460","volume":"27","author":"Chutoprapat R.","year":"2022","unstructured":"Chutoprapat R.; Kopongpanich P.; Chan L.W.; A mini-review on solid lipid nanoparticles and nanostructured lipid carriers: Topical delivery of phytochemicals for the treatment of acne vulgaris. Molecules  2022,27(11),3460","journal-title":"Molecules"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"104149","DOI":"10.1016\/j.jddst.2023.104149","volume":"80","author":"Pawar R.","year":"2023","unstructured":"Pawar R.; Dawre S.; Solid lipid nanoparticles dispersed topical hydrogel for co-delivery of adapalene and minocycline for acne treatment. J Drug Deliv Sci Technol  2023,80,104149","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1080\/02652048.2020.1823499","volume":"37","author":"Gupta S.","year":"2020","unstructured":"Gupta S.; Wairkar S.; Bhatt L.K.; Isotretinoin and \u03b1-tocopherol acetate-loaded solid lipid nanoparticle topical gel for the treatment of acne. J Microencapsul  2020,37(8),557-565","journal-title":"J Microencapsul"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"104158","DOI":"10.1016\/j.jddst.2023.104158","volume":"80","author":"Nautiyal A.","year":"2023","unstructured":"Nautiyal A.; Wairkar S.; A reduced dose of Azelaic acid-loaded solid lipid nanoparticles for treatment of hyperpigmentation: In vitro characterization and cell line studies. J Drug Deliv Sci Technol  2023,80,104158","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"753","DOI":"10.2174\/0113816128334441241108050528","volume":"31","author":"Parua P.","year":"2024","unstructured":"Parua P.; Ghosh S.; Jana K.; Therapeutic potential of neutralizing monoclonal antibodies (nMAbs) against SARS-CoV-2 Omicron Variant. Curr Pharm Des  2024,31(10),753-773","journal-title":"Curr Pharm Des"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12906-024-04440-2","volume":"24","author":"Fahimnia F.","year":"2024","unstructured":"Fahimnia F.; Nemattalab M.; Hesari Z.; Development and characterization of a topical gel, containing lavender (Lavandula angustifolia) oil loaded solid lipid nanoparticles. BMC Complement Med Ther  2024,24(1),155","journal-title":"BMC Complement Med Ther"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3390\/pharmaceutics15061593","volume":"15","author":"Viegas C.","year":"2023","unstructured":"Viegas C.; Patr\u00edcio A.B.; Prata J.M.; Nadhman A.; Chintamaneni P.K.; Fonte P.; Solid lipid nanoparticles vs. nanostructured lipid carriers: A comparative review. Pharmaceutics  2023,15(6),1593","journal-title":"Pharmaceutics"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.3390\/pharmaceutics13091454","volume":"13","author":"Ferreira K.C.B.","year":"2021","unstructured":"Ferreira K.C.B.; Valle A.B.C.S.; Paes C.Q.; Tavares G.D.; Pittella F.; Nanostructured lipid carriers for the formulation of topical anti-inflammatory nanomedicines based on natural substances. Pharmaceutics  2021,13(9),1454","journal-title":"Pharmaceutics"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"7168","DOI":"10.1021\/acsnano.2c02347","volume":"16","author":"Xu Y.","year":"2022","unstructured":"Xu Y.; Fourniols T.; Labrak Y.; Pr\u00e9at V.; Beloqui A.; des Rieux A.; Surface modification of lipid-based nanoparticles. ACS Nano  2022,16(5),7168-7196","journal-title":"ACS Nano"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1021\/acsnano.4c09566","volume":"19","author":"Tenchov R.","year":"2025","unstructured":"Tenchov R.; Hughes K.J.; Ganesan M.; Transforming medicine: Cutting-edge applications of nanoscale materials in drug delivery. ACS Nano  2025,19(4),4011-4038","journal-title":"ACS Nano"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/pharmaceutics16030396","volume":"16","author":"Ahsan A.","year":"2024","unstructured":"Ahsan A.; Thomas N.; Barnes T.J.; Lipid nanocarriers-enabled delivery of antibiotics and antimicrobial adjuvants to overcome bacterial biofilms. Pharmaceutics  2024,16(3),396","journal-title":"Pharmaceutics"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"118781","DOI":"10.1016\/j.ijpharm.2019.118781","volume":"572","author":"Elmowafy M.","year":"2019","unstructured":"Elmowafy M.; Shalaby K.; Ali H.M.; Impact of nanostructured lipid carriers on dapsone delivery to the skin: In vitro and in vivo studies. Int J Pharm  2019,572,118781","journal-title":"Int J Pharm"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1111\/jocd.16415","volume":"23","author":"Zhong J.","year":"2024","unstructured":"Zhong J.; Zhao N.; Song Q.; Du Z.; Shu P.; Topical retinoids: Novel derivatives, nano lipid\u2010based carriers, and combinations to improve chemical instability and skin irritation. J Cosmet Dermatol  2024,23(10),3102-3115","journal-title":"J Cosmet Dermatol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"101418","DOI":"10.1016\/j.jddst.2019.101418","volume":"55","author":"Malik D.S.","year":"2020","unstructured":"Malik D.S.; Kaur G.; Exploring therapeutic potential of azelaic acid loaded NLCs for the treatment of acne vulgaris. J Drug Deliv Sci Technol  2020,55,101418","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/pharmaceutics16030309","volume":"16","author":"Dragicevic N.","year":"2024","unstructured":"Dragicevic N.; Maibach H.I.; Liposomes and other nanocarriers for the treatment of acne vulgaris: Improved therapeutic efficacy and skin tolerability. Pharmaceutics  2024,16(3),309","journal-title":"Pharmaceutics"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.2217\/nnm-2023-0176","volume":"18","author":"Safaei M.","year":"2023","unstructured":"Safaei M.; Khalighi F.; Behabadi F.A.; Liposomal nanocarriers containing siRNA as small molecule-based drugs to overcome cancer drug resistance. Nanomedicine  2023,18(24),1745-1768","journal-title":"Nanomedicine"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.3390\/pharmaceutics15122685","volume":"15","author":"\u015eahin Bektay H.","year":"2023","unstructured":"\u015eahin Bektay H.; Sa\u011f\u0131ro\u011flu A.A.; Bozali K.; G\u00fcler E.M.; G\u00fcng\u00f6r S.; The design and optimization of ceramide NP-loaded liposomes to restore the skin barrier. Pharmaceutics  2023,15(12),2685","journal-title":"Pharmaceutics"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/bioengineering12020133","volume":"12","author":"Liu X.","year":"2025","unstructured":"Liu X.; Falconer R.A.; Liposomal nanocarriers to enhance skin delivery of chemotherapeutics in cancer therapy. Bioengineering  2025,12(2),133","journal-title":"Bioengineering"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jconrel.2023.02.006","volume":"355","author":"Guillot A.J.","year":"2023","unstructured":"Guillot A.J.; Mart\u00ednez-Navarrete M.; Garrigues T.M.; Melero A.; Skin drug delivery using lipid vesicles: A starting guideline for their development. J Control Release  2023,355,624-654","journal-title":"J Control Release"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.3390\/molecules27082504","volume":"27","author":"Wu W.","year":"2022","unstructured":"Wu W.; Wang Z.; Wu Y.; Mechanisms of penetration enhancement and transport utilizing skin keratine liposomes for the topical delivery of licochalcone A. Molecules  2022,27(8),2504","journal-title":"Molecules"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"115028","DOI":"10.1016\/j.addr.2023.115028","volume":"200","author":"Jahromi L.P.","year":"2023","unstructured":"Jahromi L.P.; Rothammer M.; Fuhrmann G.; Polysaccharide hydrogel platforms as suitable carriers of liposomes and extracellular vesicles for dermal applications. Adv Drug Deliv Rev  2023,200,115028","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/gels9020135","volume":"9","author":"Arooj A.","year":"2023","unstructured":"Arooj A.; Rehman A.U.; Iqbal M.; Naz I.; Alhodaib A.; Ahmed N.; Development of adapalene loaded liposome based gel for acne. Gels  2023,9(2),135","journal-title":"Gels"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1039\/D0BM01712D","volume":"9","author":"Alvi S.B.","year":"2021","unstructured":"Alvi S.B.; Rajalakshmi P.S.; Jogdand A.; Iontophoresis mediated localized delivery of liposomal gold nanoparticles for photothermal and photodynamic therapy of acne. Biomater Sci  2021,9(4),1421-1430","journal-title":"Biomater Sci"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.2147\/IJN.S416966","volume":"18","author":"Tsai M.J.","year":"2023","unstructured":"Tsai M.J.; Lin C.Y.; Trousil J.; Proteinase K\/retinoic acid-loaded cationic liposomes as multifunctional anti-acne therapy to disorganize biofilm and regulate keratinocyte proliferation. Int J Nanomedicine  2023,18,3879-3896","journal-title":"Int J Nanomedicine"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3390\/pharmaceutics12070688","volume":"12","author":"Anestopoulos I.","year":"2020","unstructured":"Anestopoulos I.; Kiousi D.E.; Klavaris A.; Surface active agents and their health-promoting properties: Molecules of multifunctional significance. Pharmaceutics  2020,12(7),688","journal-title":"Pharmaceutics"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.biopha.2018.10.021","volume":"108","author":"Shukla T.","year":"2018","unstructured":"Shukla T.; Upmanyu N.; Agrawal M.; Saraf S.; Saraf S.; Alexander A.; Biomedical applications of microemulsion through dermal and transdermal route. Biomed Pharmacother  2018,108,1477-1494","journal-title":"Biomed Pharmacother"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.3390\/pr11123409","volume":"11","author":"Qu J.","year":"2023","unstructured":"Qu J.; Wan Y.; Tian M.; Lv W.; Microemulsions based on diverse surfactant molecular structure: Comparative analysis and mechanistic study. Processes  2023,11(12),3409","journal-title":"Processes"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1201\/9780429202971-36","author":"Tessema E.N.","year":"2021","unstructured":"Tessema E.N.; Heuschkel S.; Shukla A.; Neubert R.H.H.; Use of microemulsions for topical drug delivery. In: Percutaneous Absorption  2021,479-502","journal-title":"In: Percutaneous Absorption"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1208\/s12249-021-01989-w","volume":"22","author":"Shao B.","year":"2021","unstructured":"Shao B.; Sun L.; Xu N.; Gu H.; Ji H.; Wu L.; Development and evaluation of topical delivery of microemulsions containing adapalene (MEs-Ap) for acne. AAPS PharmSciTech  2021,22(3),125","journal-title":"AAPS PharmSciTech"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"100185","DOI":"10.1016\/j.ijpx.2023.100185","volume":"5","author":"Badawi N.M.","year":"2023","unstructured":"Badawi N.M.; Yehia R.M.; Lamie C.; Abdelrahman K.A.; Attia D.A.; Helal D.A.; Tackling acne vulgaris by fabrication of tazarotene-loaded essential oil-based microemulsion: In vitro and in vivo evaluation. Int J Pharm X  2023,5,100185","journal-title":"Int J Pharm X"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"101835","DOI":"10.1016\/j.jddst.2020.101835","volume":"58","author":"Gull A.","year":"2020","unstructured":"Gull A.; Ahmed S.; Ahmad F.J.; Nagaich U.; Chandra A.; Hydrogel thickened microemulsion; a local cargo for the co- delivery of cinnamaldehyde and berberine to treat acne vulgaris. J Drug Deliv Sci Technol  2020,58,101835","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"239","DOI":"10.34172\/apb.2020.028","volume":"10","author":"Salimi A.","year":"2020","unstructured":"Salimi A.; Zadeh B.S.M.; Godazgari S.; Rahdar A.; Development and evaluation of azelaic acid-loaded microemulsion for transfollicular drug delivery through guinea pig skin: A mechanistic study. Adv Pharm Bull  2020,10(2),239-246","journal-title":"Adv Pharm Bull"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3390\/pharmaceutics14040726","volume":"14","author":"Li D.","year":"2022","unstructured":"Li D.; Martini N.; Wu Z.; Niosomal nanocarriers for enhanced dermal delivery of epigallocatechin gallate for protection against oxidative stress of the skin. Pharmaceutics  2022,14(4),726","journal-title":"Pharmaceutics"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"9668","DOI":"10.3390\/ijms23179668","volume":"23","author":"Witika B.A.","year":"2022","unstructured":"Witika B.A.; Bassey K.E.; Demana P.H.; Siwe-Noundou X.; Poka M.S.; Current advances in specialised niosomal drug delivery: Manufacture, characterization and drug delivery applications. Int J Mol Sci  2022,23(17),9668","journal-title":"Int J Mol Sci"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"8319","DOI":"10.3390\/ijms22158319","volume":"22","author":"Sguizzato M.","year":"2021","unstructured":"Sguizzato M.; Esposito E.; Cortesi R.; Lipid-based nanosystems as a tool to overcome skin barrier. Int J Mol Sci  2021,22(15),8319","journal-title":"Int J Mol Sci"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12247-024-09807-z","volume":"19","author":"Rezaeizadeh M.","year":"2024","unstructured":"Rezaeizadeh M.; Eskanlou A.; Pardakhty A.; Pournamdari M.; Daneshpajooh M.; Preparation and physicochemical characterizations of niosomal benzoyl peroxide and clindamycin phosphate formulation for acne vulgaris. J Pharm Innov  2024,19(1),1","journal-title":"J Pharm Innov"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1642653","DOI":"10.1155\/2024\/1642653","volume":"2024","author":"Kanpipit N.","year":"2024","unstructured":"Kanpipit N.; Thapphasaraphong S.; Phupaboon S.; Puthongking P.; The characteristics and biological activities of niosome\u2010entrapped salicylic acid\u2010contained oleoresin from Dipterocarpus alatus for skin product applications. Adv Pharmacol Pharm Sci  2024,2024(1),1642653","journal-title":"Adv Pharmacol Pharm Sci"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2174\/2211738510666220224103406","volume":"10","author":"Kashani-Asadi-Jafari F.","year":"2022","unstructured":"Kashani-Asadi-Jafari F.; Hadjizadeh A.; Niosome-encapsulated doxycycline hyclate for potentiation of acne therapy: Formulation and characterization. Pharm Nanotechnol  2022,10(1),56-68","journal-title":"Pharm Nanotechnol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1080\/08982104.2024.2339896","volume":"34","author":"Mahajan K.","year":"2024","unstructured":"Mahajan K.; Sharma P.; Abbot V.; Chauhan K.; Ethosomes as a carrier for transdermal drug delivery system: Methodology and recent developments. J Liposome Res  2024,34(4),697-714","journal-title":"J Liposome Res"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"121656","DOI":"10.1016\/j.ijpharm.2022.121656","volume":"618","author":"Paiva-Santos A.C.","year":"2022","unstructured":"Paiva-Santos A.C.; Gama M.; Peixoto D.; Nanocarrier-based dermopharmaceutical formulations for the topical management of atopic dermatitis. Int J Pharm  2022,618,121656","journal-title":"Int J Pharm"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s11095-021-03053-5","volume":"38","author":"Paiva-Santos A.C.","year":"2021","unstructured":"Paiva-Santos A.C.; Silva A.L.; Guerra C.; Ethosomes as nanocarriers for the development of skin delivery formulations. Pharm Res  2021,38(6),947-970","journal-title":"Pharm Res"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/08982104.2021.1968430","volume":"32","author":"Gupta M.K.","year":"2022","unstructured":"Gupta M.K.; Sansare V.; Shrivastava B.; Jadhav S.; Gurav P.; Comprehensive review on use of phospholipid based vesicles for phytoactive delivery. J Liposome Res  2022,32(3),211-223","journal-title":"J Liposome Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/10837450.2020.1860087","volume":"26","author":"Nair R.S.","year":"2021","unstructured":"Nair R.S.; Billa N.; Leong C.O.; Morris A.P.; An evaluation of tocotrienol ethosomes for transdermal delivery using Strat-M \u00ae membrane and excised human skin. Pharm Dev Technol  2021,26(2),243-251","journal-title":"Pharm Dev Technol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1039\/D0RA09561C","volume":"11","author":"Richard C.","year":"2021","unstructured":"Richard C.; Cassel S.; Blanzat M.; Vesicular systems for dermal and transdermal drug delivery. RSC Advances  2021,11(1),442-451","journal-title":"RSC Advances"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/jocd.15895","volume":"23","author":"Abu-Huwaij R.","year":"2024","unstructured":"Abu-Huwaij R.; Zidan A.N.; Unlocking the potential of cosmetic dermal delivery with ethosomes: A comprehensive review. J Cosmet Dermatol  2024,23(1),17-26","journal-title":"J Cosmet Dermatol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.2174\/1381612829666230526142421","volume":"29","author":"Kar B.","year":"2023","unstructured":"Kar B.; Pradhan D.; Halder J.; Rai V.K.; Ghosh G.; Rath G.; Antiviral application of carbohydrate polymers: A review. Curr Pharm Des  2023,29(18),1441-1458","journal-title":"Curr Pharm Des"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s13205-021-02978-3","volume":"11","author":"Ansari SA","year":"2021","unstructured":"Ansari SA; Qadir A; Warsi MH; Ethosomes-based gel formulation of karanjin for treatment of acne vulgaris: In vitro investigations and preclinical assessment. 3 Biotech  2021,11(11),456","journal-title":"3 Biotech"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.2174\/0113816128313713240628063301","volume":"30","author":"Kar B.","year":"2024","unstructured":"Kar B.; Rout S.R.; Halder J.; The recent development of luteolin-loaded nanocarrier in targeting cancer. Curr Pharm Des  2024,30(27),2129-2141","journal-title":"Curr Pharm Des"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4155\/tde-2021-0059","volume":"13","author":"Bisht A.","year":"2022","unstructured":"Bisht A.; Hemrajani C.; Upadhyay N.; Azelaic acid and Melaleuca alternifolia essential oil co-loaded vesicular carrier for combinational therapy of acne. Ther Deliv  2022,13(1),13-29","journal-title":"Ther Deliv"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"0159967","DOI":"10.1371\/journal.pone.0159967","volume":"11","author":"Yu Z.","year":"2016","unstructured":"Yu Z.; Lv H.; Han G.; Ma K.; Ethosomes loaded with cryptotanshinone for acne treatment through topical gel formulation. PLoS One  2016,11(7),0159967","journal-title":"PLoS One"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"19326","DOI":"10.1016\/j.heliyon.2023.e19326","volume":"9","author":"Khan H.M.S.","year":"2023","unstructured":"Khan H.M.S.; Tanveer N.; Arshad T.; Rasool F.; Uddin M.N.; Kazi M.; Encapsulation of alpha arbutin, a depigmenting agent, in nanosized ethosomes: In vitro and in vivo human studies. Heliyon  2023,9(9),19326","journal-title":"Heliyon"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"105211","DOI":"10.1016\/j.jddst.2023.105211","volume":"91","author":"Alfehaid F.S.","year":"2024","unstructured":"Alfehaid F.S.; Nair A.B.; Shah H.; Enhanced transdermal delivery of apremilast loaded ethosomes: Optimization, characterization and in vivo evaluation. J Drug Deliv Sci Technol  2024,91,105211","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"119936","DOI":"10.1016\/j.ijpharm.2020.119936","volume":"592","author":"Li Y.","year":"2021","unstructured":"Li Y.; Xu F.; Li X.; Development of curcumin-loaded composite phospholipid ethosomes for enhanced skin permeability and vesicle stability. Int J Pharm  2021,592,119936","journal-title":"Int J Pharm"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"453","DOI":"10.5530\/ijper.58.2.51","volume":"58","author":"Ghangas S.","year":"2024","unstructured":"Ghangas S.; Ashok P.K.; Hooda T.; Enhancing oral bioavailability of isotretinoin by using solid lipid nanoparticles (SLNs). Indian J Pharm Educ Res  2024,58(2),453-459","journal-title":"Indian J Pharm Educ Res"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/10667857.2021.1873637","volume":"37","author":"Sharma S.","year":"2022","unstructured":"Sharma S.; Kanugo A.; Gaikwad J.; Design and development of solid lipid nanoparticles of tazarotene for the treatment of psoriasis and acne: A quality by design approach. Mater Technol  2022,37(8),735-744","journal-title":"Mater Technol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"45","DOI":"10.25004\/IJPSDR.2019.110107","volume":"11","author":"Aland R.","year":"2019","unstructured":"Aland R.; Ganesan M.; Rao P.R.; In vivo evaluation of tazarotene solid lipid nanoparticles gel for topical delivery. Int J Pharm Sci Drug Res  2019,11,45-50","journal-title":"Int J Pharm Sci Drug Res"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"17395","DOI":"10.1590\/s2175-97902019000217395","volume":"55","author":"Dhillon P.","year":"2019","unstructured":"Dhillon P.; Mirza M.A.; Anwer M.K.; Alshetaili A.S.; Alshahrani S.M.; Iqbal Z.; Development and optimization of erythromycin-loaded lipid-based gel by Taguchi design: In vitro characterization and antimicrobial evaluation. Braz J Pharm Sci  2019,55,17395","journal-title":"Braz J Pharm Sci"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2217\/nnm-2021-0031","volume":"16","author":"Lima F.A.","year":"2021","unstructured":"Lima F.A.; Vilela R.V.R.; Or\u00e9fice R.L.; Nanostructured lipid carriers enhances the safety profile of tretinoin: In vitro and healthy human volunteers\u2019 studies. Nanomedicine  2021,16(16),1391-1409","journal-title":"Nanomedicine"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.2147\/IJN.S497108","volume":"20","author":"Abid F.","year":"2025","unstructured":"Abid F.; Kim S.; Savaliya B.; Targeting acne: Development of monensin-loaded nanostructured lipid carriers. Int J Nanomedicine  2025,20,2181-2204","journal-title":"Int J Nanomedicine"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1080\/02726351.2017.1305026","volume":"36","author":"Patwekar S.L.","year":"2018","unstructured":"Patwekar S.L.; Pedewad S.R.; Gattani S.; Development and evaluation of nanostructured lipid carriers-based gel of isotretinoin. Particul Sci Technol  2018,36(7),832-843","journal-title":"Particul Sci Technol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"101253","DOI":"10.1016\/j.jddst.2019.101253","volume":"54","author":"Fatima N.","year":"2019","unstructured":"Fatima N.; Rehman S.; Nabi B.; Baboota S.; Ali J.; Harnessing nanotechnology for enhanced topical delivery of clindamycin phosphate. J Drug Deliv Sci Technol  2019,54,101253","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"26","DOI":"10.9734\/jpri\/2021\/v33i40B32260","volume":"33","author":"Shettigar P.","year":"2021","unstructured":"Shettigar P.; Koland M.; Sindhoor S.M.; Prabhu A.; Formulation and evaluation of clarithromycin loaded nanostructured lipid carriers for the treatment of acne. J Pharm Res Int  2021,33,26-38","journal-title":"J Pharm Res Int"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4028\/www.scientific.net\/KEM.901.129","volume":"901","author":"Leelaudomlipi P.","year":"2021","unstructured":"Leelaudomlipi P.; Manchun S.; Supakdamrongkul P.; Sobharaksha P.; Preparation of nanostructured lipid carriers (NLCs) loading violacein extract for anti-acne products. Key Eng Mater  2021,901,129-136","journal-title":"Key Eng Mater"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/08982104.2019.1630646","volume":"30","author":"Ero\u011flu \u0130.","year":"2020","unstructured":"Ero\u011flu \u0130.; Aslan M.; Yaman \u00dc.; Liposome-based combination therapy for acne treatment. J Liposome Res  2020,30(3),263-273","journal-title":"J Liposome Res"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1080\/03639045.2018.1546310","volume":"45","author":"Madan S.","year":"2019","unstructured":"Madan S.; Nehate C.; Barman T.K.; Rathore A.S.; Koul V.; Design, preparation, and evaluation of liposomal gel formulations for treatment of acne: In vitro and in vivo studies. Drug Dev Ind Pharm  2019,45(3),395-404","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"38","DOI":"10.55124\/jdcr.v2i1.233","volume":"2","author":"Dawre S","year":"2023","unstructured":"Dawre S; Agarwal S; Development and characterization of adapalene loaded microemulsion-based hydrogel for acne treatment adapalene microemulsion. Int J Drug Deliv Control Release  2023,2(1),38-44","journal-title":"Int J Drug Deliv Control Release"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/jocd.15933","volume":"23","author":"Salimi A.","year":"2024","unstructured":"Salimi A.; Sharifmakhmalzadeh B.; amirabadi F.; Design and evaluation of adapalene microemulsion for transfollicular drug delivery through guinea pig skin. J Cosmet Dermatol  2024,23(1),289-295","journal-title":"J Cosmet Dermatol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"254686","DOI":"10.55674\/cs.v16i2.254686","volume":"16","author":"Meenongwa A.","year":"2024","unstructured":"Meenongwa A.; Keawbankrud W.; Pimsee P.; Rattanabun W.; Phungsara N.; Niosome gels encapsulate green mangosteen peel extract (Garcinia mangostana L.) as an anti-acne-inducing bacterial and anti-inflammatory activity. Creative Science  2024,16(2),254686","journal-title":"Creative Science"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1080\/10717544.2022.2048131","volume":"29","author":"Habib B.A.","year":"2022","unstructured":"Habib B.A.; Abdeltawab N.F.; Salah Ad-Din I.; D-optimal mixture design for optimization of topical dapsone niosomes: In vitro characterization and in vivo activity against Cutibacterium acnes. Drug Deliv  2022,29(1),821-836","journal-title":"Drug Deliv"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.2147\/IJN.S476937","volume":"20","author":"Liu R.","year":"2025","unstructured":"Liu R.; Li M.; Zhu Q.; Development and characterization of a hydrogel containing chloramphenicol-loaded binary ethosomes for effective transdermal permeation and treatment acne in rat model. Int J Nanomedicine  2025,20,1697-1715","journal-title":"Int J Nanomedicine"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4103\/japtr.JAPTR_289_18","volume":"10","author":"Iskandarsyah I.","year":"2019","unstructured":"Iskandarsyah I.; Apriani E.F.; Rosana Y.; Formulation, characterization, and in vitro testing of azelaic acid ethosome-based cream against Propionibacterium acnes for the treatment of acne. J Adv Pharm Technol Res  2019,10(2),75-80","journal-title":"J Adv Pharm Technol Res"},{"key":"ref=116","year":"2011","unstructured":"Superior efficacy of azithromycin and levamisole versus of azithromycin alone in the treatment of inflammatory acne vulgaris: An investigator blind randomized clinical trial on 169 patients; NCT01348321.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT01348321.2011"},{"key":"ref=117","year":"2015","unstructured":"A multi-center, double-blind, randomized, placebo controlled, parallel-group study comparing adapalene gel 0.3% to differin\u00ae (Adapalene Gel 0.3%) and both active treatments to a placebo control in the treatment of acne vulgaris; NCT02411942.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT02411942.2015"},{"key":"ref=118","year":"2023","unstructured":"Intralesional injections of triamcinolone for acne vulgaris; NCT06170593.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT06170593.2023"},{"key":"ref=119","year":"2018","unstructured":"A phase 3 multi-center, double-blind, randomized, vehiclecontrolled study of S6G5T-3 in the treatment of acne vulgaris; NCT03761784.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT03761784.2018"},{"key":"ref=120","year":"2013","unstructured":"A long term study of GK530G in subjects with acne vulgaris; NCT01910064.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT01910064.2013"},{"key":"ref=121","year":"2019","unstructured":"A prospective, multicenter, randomized, double-blind, vehiclecontrolled phase 2 study to evaluate the safety and efficacy of a combination of 3% minocycline and 0.3% adapalene topical foam formulation for the treatment of moderate-to-severe acne (study FX2016 40); NCT04104685.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT04104685.2019"},{"key":"ref=122","year":"2017","unstructured":"Randomized double-blind study on the benefit of spironolactone for treating acne of adult woman; NCT03334682.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT03334682.2017"},{"key":"ref=123","year":"2016","unstructured":"Efficacy and safety of adapalene 0.3%\/benzoyl peroxide 2.5% gel plus doxycycline in severe inflammatory acne (non-nodulocystic) Subjects; NCT02899000.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT02899000.2016"},{"key":"ref=124","year":"2019","unstructured":"A study of tolerability, safety, and efficacy, of DMT310 in patients with acne vulgaris; NCT04106778.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT04106778.2019"},{"key":"ref=125","year":"2014","unstructured":"A long-term safety and efficacy study of CD5789 (Trifarotene) 50 \u03bcg\/g cream in subjects with acne vulgaris; NCT02189629.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT02189629.2014"},{"key":"ref=126","year":"2019","unstructured":"A randomized controlled trial of efficiency of moisturizer containing Licochalcone A, Decanediol, L-carnitine and salicylic acid in reducing relapsing of acne in thai acne subjects; NCT04002024.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT04002024.2019"},{"key":"ref=127","year":"2011","unstructured":"A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of gevokizumab in subjects with moderate to severe acne vulgaris; NCT01498874.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT01498874.2011"},{"key":"ref=128","year":"2017","unstructured":"A randomized, double-blind, vehicle controlled, efficacy and safety study of olumacostat glasaretil gel in subjects with acne vulgaris; NCT03073486.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT03073486.2017"},{"key":"ref=129","year":"2018","unstructured":"An open-label study to investigate the efficacy and tolerability of aczone gel, 7.5% in the treatment of acne vulgaris in men and women with skin of color; NCT03681470.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT03681470.2018"},{"key":"ref=130","year":"2021","unstructured":"A phase 3, multi-center, randomized, double-blind, vehiclecontrolled study to evaluate the efficacy and safety of topical administration of minocycline hydrochloride foam (4%) in the treatment of moderate-to-severe acne vulgaris; NCT04960930.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT04960930.2021"},{"key":"ref=131","year":"2019","unstructured":"A phase 3, multicenter, randomized, double-blind, vehicle controlled, parallel-group, clinical study comparing the efficacy and safety of IDP-126 gel in the treatment of acne vulgaris; NCT04214652.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT04214652.2019"},{"key":"ref=132","year":"2015","unstructured":"Benzaknen\u00ae 5% gel in combination with dermotivin\u00ae soft liquid soap and non-comedogenic Cetaphil\u00ae dermacontrol moisturizer SPF30 in the treatment of mild-to-moderate acne vulgaris; NCT02589405.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT02589405.2015"},{"key":"ref=133","year":"2016","unstructured":"An open-label, long-term extension study to evaluate the safety of cortexolone 17\u03b1-propionate (CB-03-01) cream, 1% applied twicedaily in subjects with acne vulgaris; NCT02682264.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT02682264.2016"},{"key":"ref=134","year":"2015","unstructured":"A multi-center open-label evaluation of the safety of sarecycline tablets in the treatment of acne vulgaris; NCT02413346.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT02413346.2015"},{"key":"ref=135","year":"2013","unstructured":"A safety and efficacy study to compare dapsone dermal gel with vehicle control in patients with acne vulgaris; NCT01974141.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT01974141.2013"},{"key":"ref=136","year":"2022","unstructured":"Evaluation of the effectiveness and tolerance of effaclar ultra concentrated serum in women with mandibular acne for 3 months (including 2 months of treatment); NCT05457621.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT05457621.2022"},{"key":"ref=137","year":"2008","unstructured":"Randomized, open-label study to evaluate the efficacy and safety of doryx tablets compared to doxycycline hyclate in the treatment of acne vulgaris; NCT00635609.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT00635609.2008"},{"key":"ref=138","year":"2015","unstructured":"A phase 2, randomized, double-blind, vehicle-controlled, parallel group multicenter study to evaluate the safety and efficacy of CLS001 topical gel versus vehicle applied once daily for 12 weeks to female subjects with moderate to severe acne vulgaris; NCT02571998.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT02571998.2015"},{"key":"ref=139","year":"2012","unstructured":"Innate immunity in acne vulgaris; NCT01694433.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT01694433.2012"},{"key":"ref=140","year":"2009","unstructured":"Monocentric study, prospective, open and non controlled for to evaluate the effectiveness, and tolerability the safety of association of clindamycin phosphate 1.2% and tretinoin 0,025% in the treatment of acne vulgaris mild to moderate, when used once daily for 12 weeks; NCT00838812.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT00838812.2009"},{"key":"ref=141","year":"2024","unstructured":"A clinical study to assess the barrier impact of winlevi; NCT06415292.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT06415292.2024"},{"key":"ref=142","year":"2002","unstructured":"A 12-week, randomized, double-blind, multicenter study comparing the clinical efficacy and safety of azelaic acid 15% gel (SH H 655 BA) with its vehicle (SH H 655 PBA) in patients with mild to moderate acne; NCT00031096.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT00031096.2002"},{"key":"ref=143","year":"2018","unstructured":"Efficacy of microneedling with topical vitamin c in treatment of acne scarring; NCT03522922.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT03522922.2018"},{"key":"ref=144","year":"2014","unstructured":"Clinical study for the effectiveness and safety of topical lupeol in mild to moderate acne; NCT02205892.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT02205892.2014"},{"key":"ref=145","year":"2014","unstructured":"An evaluator-blind, randomized, vehicle-controlled efficiency of adjunctive usage of a moisturizer containing Licochalcone A, Lcarnitine and 1,2-decanediol with adapalene gel for improvement of local tolerance in thai acne subjects; NCT02173054.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT02173054.2014"},{"key":"ref=146","year":"2018","unstructured":"The use of onexton in moderate acne vulgaris for patients with skin of color; NCT03402893.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT03402893.2018"},{"key":"ref=147","year":"2009","unstructured":"A study of safety and efficacy of topical methylaminolevulinate 8mg\/g with and without occlusion followed by red light exposure in subjects with facial acne; NCT00833183.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT00833183.2009"},{"key":"ref=148","year":"2010","unstructured":"A study of the revlite q-switched neodymium: Yttrium-aluminumgarnet (Nd:YAG) laser for the treatment of acne scars in fitzpatrick skin types III-VI; NCT01221922.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT01221922.2010"},{"key":"ref=149","year":"2002","unstructured":"A multicenter, randomized, double-blind, placebo-controlled, clinical trial to determine the effects of doxycycline hyclate 20 mg tablets [Periostat(R)] administered twice daily for the treatment of acne rosacea; NCT00041977.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT00041977.2002"},{"key":"ref=150","year":"2013","unstructured":"Efficacy of 45mg oral minocycline (solodyn) and 45mg oral minocycline (solodyn) plus 15% azelaic acid (finacea) in the treatment of acne rosacea; NCT05014906.  Available from:  https:\/\/clinicaltrials.gov\/study\/NCT05014906.2013"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/cosmetics8030084","volume":"8","author":"Ahmad J.","year":"2021","unstructured":"Ahmad J.; Lipid nanoparticles based cosmetics with potential application in alleviating skin disorders. Cosmetics  2021,8(3),84","journal-title":"Cosmetics"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3390\/antiox13121516","volume":"13","author":"Ricci A.","year":"2024","unstructured":"Ricci A.; Stefanuto L.; Gasperi T.; Bruni F.; Tofani D.; Lipid nanovesicles for antioxidant delivery in skin: Liposomes, ufasomes, ethosomes, and niosomes. Antioxidants  2024,13(12),1516","journal-title":"Antioxidants"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.lfs.2017.08.003","volume":"186","author":"Cao Y.","year":"2017","unstructured":"Cao Y.; Long J.; Liu L.; A review of endoplasmic reticulum (ER) stress and nanoparticle (NP) exposure. Life Sci  2017,186,33-42","journal-title":"Life Sci"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"16591","DOI":"10.1038\/s41598-021-96043-x","volume":"11","author":"Okoro O.E.","year":"2021","unstructured":"Okoro O.E.; Adenle A.; Ludovici M.; Truglio M.; Marini F.; Camera E.; Lipidomics of facial sebum in the comparison between acne and non-acne adolescents with dark skin. Sci Rep  2021,11(1),16591","journal-title":"Sci Rep"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3390\/pharmaceutics13091501","volume":"13","author":"Folle C.","year":"2021","unstructured":"Folle C.; D\u00edaz-Garrido N.; S\u00e1nchez-L\u00f3pez E.; Surface-modified multifunctional thymol-loaded biodegradable nanoparticles for topical acne treatment. Pharmaceutics  2021,13(9),1501","journal-title":"Pharmaceutics"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"71407","DOI":"10.1109\/ACCESS.2023.3295001","volume":"11","author":"Vatiwutipong P","year":"2023","unstructured":"Vatiwutipong P; Vachmanus S; Noraset T; Tuarob S; Artificial intelligence in cosmetic dermatology: A systematic literature review. IEEE Access  2023,11,71407-25","journal-title":"IEEE Access"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"105740","DOI":"10.1016\/j.jddst.2024.105740","volume":"97","author":"El-Kayal M.","year":"2024","unstructured":"El-Kayal M.; Hatem S.; A comparative study between nanostructured lipid carriers and invasomes for the topical delivery of luteolin: Design, optimization and pre-clinical investigations for psoriasis treatment. J Drug Deliv Sci Technol  2024,97,105740","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"105002","DOI":"10.1016\/j.jddst.2023.105002","volume":"89","author":"Nayeem U.","year":"2023","unstructured":"Nayeem U.; Garg A.; Das A.K.; Development and evaluation of the novel chitosan-based 1% clindamycin and 2.5% benzoyl peroxide transferosomal gel for topical acne treatment. J Drug Deliv Sci Technol  2023,89,105002","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"103097","DOI":"10.1016\/j.jddst.2022.103097","volume":"68","author":"Zakaria F.","year":"2022","unstructured":"Zakaria F.; Ashari S.E.; Mat Azmi I.D.; Abdul Rahman M.B.; Recent advances in encapsulation of drug delivery (active substance) in cubosomes for skin diseases. J Drug Deliv Sci Technol  2022,68,103097","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"123980","DOI":"10.1016\/j.ijpharm.2024.123980","volume":"654","author":"Chutoprapat R.","year":"2024","unstructured":"Chutoprapat R.; Witarat J.; Jongpanyangarm P.; Mang Sung Thluai L.; Khankaew P.; Wah Chan L.; Development of solid lipid microparticles (SLMs) containing asiatic acid for topical treatment of acne: Characterization, stability, in vitro and in vivo anti-acne assessment. Int J Pharm  2024,654,123980","journal-title":"Int J Pharm"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/ics.12942","volume":"46","author":"Su Q.","year":"2024","unstructured":"Su Q.; Hu X.; Yang M.; He H.; Jia Y.; Lipidomic analysis of facial skin surface lipids in acne in young women. Int J Cosmet Sci  2024,46(3),424-436","journal-title":"Int J Cosmet Sci"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/ph14040362","volume":"14","author":"Manita P.G.","year":"2021","unstructured":"Manita P.G.; Garcia-Orue I.; Santos-Vizcaino E.; Hernandez R.M.; Igartua M.; 3D bioprinting of functional skin substitutes: From current achievements to future goals. Pharmaceuticals  2021,14(4),362","journal-title":"Pharmaceuticals"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113816128404408250707111455","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/243714\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113816128404408250707111455","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T10:23:26Z","timestamp":1767090206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/243714\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":162,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113816128404408250707111455","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-04-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}